XML 30 R20.htm IDEA: XBRL DOCUMENT v3.7.0.1
Segment Information
 3 Months Ended
Mar. 31, 2017
Segment Information [Abstract]  
Segment Information

15.  Segment Information  

 

The Company has two reportable segments organized according to its products and services: Medical Devices and Preservation Services.  The Medical Devices segment includes external revenues from product sales of BioGlue® Surgical Adhesive; BioFoam® Surgical Matrix; On-X products, since the acquisition of On-X; CardioGenesis cardiac laser therapy; PerClot; PhotoFix; HeRO Graft, through the second quarter of 2016; and ProCol, through the date of the sale of the ProCol product line in the first quarter of 2016.  The Preservation Services segment includes external services revenues from the preservation of cardiac and vascular tissues.  There are no intersegment revenues. 



The primary measure of segment performance, as viewed by the Company’s management, is segment gross margin, or net external revenues less cost of products and preservation services.  The Company does not segregate assets by segment; therefore, asset information is excluded from the segment disclosures below. 



The following table summarizes revenues, cost of products and preservation services, and gross margins for the Company’s operating segments (in thousands): 





 

 

 

 

 



Three Months Ended



March 31,



2017

 

2016

Revenues:

 

 

 

 

 

Medical devices

$

 27,396 

 

$

 27,018 

Preservation services

 

 17,663 

 

 

 15,998 

Total revenues

 

 45,059 

 

 

 43,016 



 

 

 

 

 

Cost of products and preservation services:

 

 

 

 

 

Medical devices

 

 8,017 

 

 

 7,003 

Preservation services

 

 7,530 

 

 

 8,392 

Total cost of products and preservation services

 

 15,547 

 

 

 15,395 



 

 

 

 

 

Gross margin:

 

 

 

 

 

Medical devices

 

 19,379 

 

 

 20,015 

Preservation services

 

 10,133 

 

 

 7,606 

Total gross margin

$

 29,512 

 

$

 27,621 



 The following table summarizes net revenues by product and service (in thousands): 



















 

 

 

 

 



Three Months Ended



March 31,



2017

 

2016

Products:

 

 

 

 

 

BioGlue and BioFoam

$

 15,681 

 

$

 15,316 

On-X

 

 8,860 

 

 

 6,715 

CardioGenesis cardiac laser therapy

 

 1,585 

 

 

 1,984 

PerClot

 

 819 

 

 

 991 

PhotoFix

 

 451 

 

 

 381 

HeRO Graft

 

--

 

 

 1,413 

ProCol

 

--

 

 

 218 

Total products

 

 27,396 

 

 

 27,018 



 

 

 

 

 

Preservation services:

 

 

 

 

 

Cardiac tissue

 

 7,502 

 

 

 6,428 

Vascular tissue

 

 10,161 

 

 

 9,570 

Total preservation services

 

 17,663 

 

 

 15,998 



 

 

 

 

 

Total revenues

$

 45,059 

 

$

 43,016